Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Financial Performance and Results of Operations
WST logo

West Pharmaceutical Posts 0.4% Revenue Growth and Launches $35M Savings Restructuring

WST10-QFiling Date: 4/24/2025
West Pharmaceutical Services Inc
Description

What this story covers

West Pharmaceutical's Q1 2025 10-Q reveals $698M net sales (up 0.4%, 2.1% organic), Proprietary Products driving biologics demand, but profits dip from restructuring charges. Strong $129M operating cash flow supports capex and buybacks; hedges manage currency/commodity risks amid stable strategy.

Story snapshot

CompanyWest Pharmaceutical Services Inc
TickerWST
VariantStandard detailed
Duration12:25
Filing type10-Q
PeriodQ1 2025
IndustryHealthcare & Pharmaceuticals
Accession0000105770-25-000036

Full Story Script

Content not available for this story.

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in